You are using an older browser version. Please use a supported version for the best MSN experience.

ONCONOVA THERAPEUTICS, INC.

NASDAQ: ONTX
3.73
-0.04
-1.06%

Sector

Healthcare

Industry

Pharmaceuticals

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.

Key People

Michael Hoffman

Chairman of the Board

Steven Fruchtman

President, Chief Executive Officer, Director

Ramesh Kumar

Chief Executive Officer, Director

Mark Guerin

Chief Financial Officer

Manoj Maniar

Senior Vice President - Product Development

  • Onconova Therapeutics Inc

  • 375 Pheasant Run

  • NEWTOWN, PA 18940-3423

  • US.Map

  • Phone: +1 267 7593681

  • Fax: +1 302 6365454

  • onconova.com

Incorporated

1998

Employees

25

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 8/27/2018

    • HOFFMAN MICHAEL B

    • Sold

    • 99,999

    • 0.46

    • 45,689.54

    • 5/29/2018

    • BIENEN HENRY S

    • Bought

    • 10,000

    • 0.38

    • 3,800.00

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 8/27/2018

      • HOFFMAN MICHAEL B

      • Sold

      • 99,999

      • 0.46

      • 45,689.54

      • 5/29/2018

      • BIENEN HENRY S

      • Bought

      • 10,000

      • 0.38

      • 3,800.00

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon